Botensilimab (anti-CTLA-4)

CAS: 2408310-37-0 货号: Ab182918
有货
级别和纯度: 无动物源 ? 无动物源(Animal Free)—— 不含动物源成分生产,降低污染风险。适用于避免动物源材料的生物制造和培养。 无载体 ? 无载体(Carrier Free)—— 不含添加的载体蛋白/稳定剂。当载体(如 BSA)会干扰偶联或敏感检测时使用。 重组 ? 重组(Recombinant)—— 通过重组表达生产,序列确定、批次稳定。适用于来源明确、无动物源的可重现蛋白。 ExactAb™ ? ExactAb™ —— 阿拉丁强调精准和验证质量的抗体系列。适用于可靠、特异性经验证的抗体应用。 低内毒素 ? 低内毒素级 —— 内毒素降至受控低水平。适用于高内毒素会造成干扰的敏感生物工作。 无叠氮钠 ? 无叠氮(Azide Free)—— 不含叠氮化钠防腐剂。适用于叠氮有毒或有抑制作用的偶联、细胞工作或检测。 已验证 ? 已验证级 —— 发布前在特定应用中确认性能。当需要试剂按声称工作的书面保证时使用。 ≥95%(SDS-PAGE&SEC-HPLC) 见COA
应用
Animal Model, ELISA, Flow Cytometry, Functional Assay
宿主种属
人(Human)
种属反应性
人(Human)
亚型
Human IgG1-REM
偶联
Unconjugated
★
规格
库存
价格
数量
100μg
Ab182918-100μg
现货 Stock Image
¥374.90
1mg
Ab182918-1mg
现货 Stock Image
¥1,874.90
5mg
Ab182918-5mg
现货 Stock Image
¥4,874.90
10mg
Ab182918-10mg
期货 Stock Image
¥10,399.90
请输入您要添加的产品数量

概述

Botensilimab (anti-CTLA4) 是一种人源抗细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 单克隆抗体,是一种先天性和适应性免疫激活剂。Botensilimab (anti-CTLA4) 可用于癌症的研究。

Botensilimab (anti-CTLA4), a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab (anti-CTLA4) can be used for the research of cancer.
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

规格

产品名称
Botensilimab (anti-CTLA-4)
别名
加巴替利单抗|博腾西单抗(抗 CTLA-4)
英文别名
ALPS5 antibody|CD 152 antibody|CD antibody|CD152 antibody|CD152 antigen antibody|CD152 isoform antibody|Celiac disease 3 antibody|CELIAC3 antibody|CTLA 4 antibody|CTLA-4 antibody|CTLA4 antibody|Cytotoxic T cell associated 4 antibody|Cytotoxic T lymphocyte antigen 4 antibody|Cytotoxic T lymphocyte associated 4 antibody|Cytotoxic T lymphocyte associated 4, soluble isoform, included antibody|Cytotoxic T lymphocyte associated antigen 4 antibody|Cytotoxic T lymphocyte associated antigen 4 short spliced form antibody|Cytotoxic T lymphocyte associated protein 4 antibody|Cytotoxic T lymphocyte associated serine esterase 4 antibody|Cytotoxic T lymphocyte protein 4 antibody|Cytotoxic T-lymphocyte protein 4 antibody|Cytotoxic T-lymphocyte-associated antigen 4 antibody|GRD4 antibody|GSE antibody|ICOS antibody|IDDM12 antibody|insulin-dependent diabetes mellitus 12 antibody|Ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4 antibody|OTTHUMP00000216623 antibody|CD|CD152 antigen|CD152|CD152IDDM12|CD28|celiac disease 3|CELIAC3|CTLA4|CTLA-4|cytotoxic T-lymphocyte antigen 4|cytotoxic T-lymphocyte protein 4|Cytotoxic T-lymphocyte-associated antigen 4|cytotoxic T-lymphocyte-associated protein 4|cytotoxic T-lymphocyte-associated serine esterase-4|GRD4|GSE|ICOS|ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4|ALPS5|IDDM12|AGEN 1181
规格或纯度
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属
人(Human)
特异性
CTLA4
种属反应性
人(Human)
偶联
Unconjugated
作用类型
抑制剂
克隆类型
重组抗体
Format
Whole IgG
亚型
Human IgG1-REM
轻链亚型
kappa
纯化方法
Protein A purified
浓度
见COA
CAS编号和信息
2408310-37-0
分子类型
抗体
产品线
生物产品
储存与运输
物理外观
Liquid
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片

Botensilimab (anti-CTLA-4) (Ab182918) - ELISA
Immobilized Recombinant Human CTLA-4 protein (rp176276) at 1.0 μg/mL can bind Botensilimab (anti-CTLA-4) (Ab182918) with the EC ₅₀   of 29.07 ng/mL.

Botensilimab (anti-CTLA-4) (Ab182918) - SEC
The purity of Botensilimab (anti-CTLA-4) (Ab182918) is more than 95% verified by HPLC.

高级数据

关联靶点(人)
CTLA4 Tclin 细胞毒性T淋巴细胞蛋白4(Cytotoxic T-lymphocyte protein 4) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
作用机制
作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ24F0910870ZJ24F0910870 分析证书 Ab182918
ZJ24F0910871ZJ24F0910871 分析证书 Ab182918
ZJ24F0910872ZJ24F0910872 分析证书 Ab182918
溶液计算器

相关产品

Ipilimumab (anti-CTLA-4)-19552,用于ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)各种应用,>95% (SDS-PAGE&SEC),细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体
Goat Anti-Human IgG H&L (HRP)-19553,用于WB,ELISA,IHC各种应用
Mouse Anti-Human IgG Antibody-19553,用于ELISA,CLIA各种应用
Mouse Anti-Human IgG H&L (HRP)-19553,用于ELISA各种应用
Mouse Anti-Human IgM Antibody-19553,用于ELISA各种应用
Human IgG-19554,>95%
Goat Anti-Human IgG Antibody-19553,用于ELISA,CLIA,LFAs,WB and other immunoassay methods各种应用,≥ 95%
Tremelimumab (anti-CTLA-4)-19552,用于ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)各种应用,>95%,细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体
Mouse Anti-Human IgA H&L Antibody-19553
Goat Anti-Human IgG (HRP)-19553
Goat Anti-Human IgG (Biotin)-19553
Goat Anti-Human IgG (APC)-19553
Goat Anti-Human IgG (Cy5)-19553
Goat Anti-Human IgG (TRITC)-19553
Goat Anti-Human IgG (PE)-19553
Goat Anti-Human IgG (FITC)-19553
Mouse Anti-Human IgE epsilon chain Antibody-19553
Goat Anti-Human IgG Fc Antibody-19553
Zalifrelimab (anti-CTLA-4)-19552,细胞毒性 T 淋巴细胞蛋白 4 抑制剂
Nurulimab (anti-CTLA-4)-19552
Human IgG2-Kappa-19554
Human IgG3-kappa-19554
Quavonlimab (anti-CTLA-4)-19552,细胞毒性 T 淋巴细胞蛋白 4 抑制剂
Human IgG1-kappa, anti-Spike RBD-19554
Human IgG4-kappa-19554
Goat Anti-Human IgG (AF647)-19553
Goat Anti-Human IgG (AF405)-19553
Human IgG (FITC)-19554
Human IgG (APC)-19554
Human IgG1(P331S/E430G)-kappa, anti-HEL-19554
Human IgG (PE)-19554
Human IgG1(D265A/N297A)-kappa, anti-HEL-19554
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL-19554
CTLA4/CD152 Mouse mAb-19552
Human IgG1(F405L)-kappa, anti-HEL-19554
Human IgG1(N297Q)-kappa, anti-HEL-19554
Human IgG (Biotin)-19554
Human IgG1(N297S)-kappa, anti-HEL-19554
Human IgG1(E233A/L235A)-kappa, anti-HEL-19554
Human IgG1(K214R/N297A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL-19554
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234F/L235E)-kappa, anti-HEL-19554
Human IgG1(D265A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL-19554
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL-19554
Human IgG1(D270N)-kappa, anti-HEL-19554
Human IgG4(S228P)-kappa, anti-HEL-19554
Human IgG1(N297A)-kappa, anti-HEL-19554
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL-19554
Human IgG1-lambda1, anti-Spike RBD-19554
Human IgG1-lambda2, anti-Spike RBD-19554
Goat Anti-Human IgG (AF555)-19553
Human IgG1-kappa (AF647), anti-Spike RBD-19554
Human IgG1-kappa (AF405), anti-Spike RBD-19554
Human IgG1-kappa (APC), anti-Spike RBD-19554
Human IgG1-kappa (Biotin), anti-Spike RBD-19554
Human IgG1-kappa (AF700), anti-Spike RBD-19554
Human IgG1-kappa (FITC), anti-Spike RBD-19554
Human IgG1-kappa (AF555), anti-Spike RBD-19554
Centrose patent anti-dysadherin (anti-Dysadherin)-19552
Human IgG (AF647)-19554
Human IgG (AF488)-19554
Human IgG (AF700)-19554
Human IgG (AF405)-19554
Goat Anti-Human IgG (AF488)-19553
Goat Anti-Human IgG Fc (Cy5)-19553
Goat Anti-Human IgG Fc (AF555)-19553
Goat Anti-Human IgG Fc (TRITC)-19553
Goat Anti-Human IgG Fc (AF700)-19553
Goat Anti-Human IgG Fc (AF405)-19553
Goat Anti-Human IgG Fc (Biotin)-19553
Goat Anti-Human IgG Fc (AF647)-19553
Goat Anti-Human IgG Fc (FITC)-19553
Human IgG (AF555)-19554